SBORNÍK PŘEDNÁŠEK - 20. SETKÁNÍ LÉKAŘŮ ČR A SR V LITOMYŠLI - ON-LINE

LITERATÚRA 1. Reinfection with SARS‑CoV-2: implementation of a surveillance case definition within the EU/EEA. https://www.ecdc.europa.eu/en/publications‑data/reinfection‑sars‑cov-2- implementation‑surveillance‑case‑definition‑within‑eueea (accessed 21 Apr2021). 2. To KK‑W et al. Coronavirus Disease 2019 (COVID-19) Re‑infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Geno‑ me Sequencing. Clin Infect, DiS. 2020. doi:10.1093/cid/ciaa1275 3. To KK‑W et al. Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection. Clin Infect, DiS. 2020: 1–4. 4. Yahav D et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re‑positivity. Clin Microbiol Infect. 2020; 0. doi:10.1016/j.cmi.2020. 11. 028 5. Babiker A et al. The Importance and Challenges of Identifying SARS‑CoV-2 Reinfections. J Clin Microbiol. 2020. doi:10.1128/JCM.02769–20 6. Reynolds CJ et al. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS‑CoV-2 infection. Sci Immunol. 2020; 5: eabf3698. 7. Fabiánová K et al. COVID-19 reinfections. Epidemiol Mikrobiol Imunol. 2021; 70: 62–67. 8. Hansen CH et al. Assessment of protection against reinfection with SARS‑CoV-2 among 4 million PCR‑tested individuals in Denmark in 2020: a population‑level observational stu‑ dy. Lancet. 2021; 397: 1204–1212. 9. Hall VJ et al. SARS‑CoV-2 infection rates of antibody‑positive compared with antibody‑negative health‑care workers in England: a large, multicentre, prospective cohort study (SI‑ REN). Lancet. 2021; 397: 1459–1469.

30

20. SETKÁNÍ LÉKAŘŮ ČR A SR V LITOMYŠLI / ON-LINE / 14. KVĚTNA 2021